Overview
Haruyasu Murakami practices practicing medicine in Shizuoka, Japan.
Murakami is highly rated in 11 conditions, according to our data. Their clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC).
They are actively involved in clinical research, co-authoring 216 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Haruyasu Murakami
Is Haruyasu Murakami a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Haruyasu Murakami is classified as an Elite expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Haruyasu Murakami participate in research or clinical trials?
Yes. Haruyasu Murakami has published 216 articles and abstracts on conditions like Lung Cancer. You can view a list of Haruyasu Murakami's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- EGFR Positive Lung Cancer
- Lung CancerMurakami isElite. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer (SCLC)
- Distinguished
- Lung AdenocarcinomaMurakami isDistinguished. Learn about Lung Adenocarcinoma.
- Advanced
- Acute Interstitial PneumoniaMurakami isAdvanced. Learn about Acute Interstitial Pneumonia.
- Febrile NeutropeniaMurakami isAdvanced. Learn about Febrile Neutropenia.
- Interstitial Lung DiseaseMurakami isAdvanced. Learn about Interstitial Lung Disease.
- PIK3CA-Related Overgrowth Spectrum
- PneumoniaMurakami isAdvanced. Learn about Pneumonia.
- Thymic Epithelial TumorMurakami isAdvanced. Learn about Thymic Epithelial Tumor.
- Experienced
- AgranulocytosisMurakami isExperienced. Learn about Agranulocytosis.
- Anal CancerMurakami isExperienced. Learn about Anal Cancer.
- Atypical PneumoniaMurakami isExperienced. Learn about Atypical Pneumonia.
- Bone TumorMurakami isExperienced. Learn about Bone Tumor.
- Brain TumorMurakami isExperienced. Learn about Brain Tumor.
- Breast CancerMurakami isExperienced. Learn about Breast Cancer.
- Cerebral HypoxiaMurakami isExperienced. Learn about Cerebral Hypoxia.
- Colorectal CancerMurakami isExperienced. Learn about Colorectal Cancer.
- EsophagitisMurakami isExperienced. Learn about Esophagitis.
- ListeriosisMurakami isExperienced. Learn about Listeriosis.
- Low Sodium LevelMurakami isExperienced. Learn about Low Sodium Level.
- Lung MetastasesMurakami isExperienced. Learn about Lung Metastases.
- MeningitisMurakami isExperienced. Learn about Meningitis.
- MesotheliomaMurakami isExperienced. Learn about Mesothelioma.
- Neuroendocrine TumorMurakami isExperienced. Learn about Neuroendocrine Tumor.
- ParonychiaMurakami isExperienced. Learn about Paronychia.
- PericarditisMurakami isExperienced. Learn about Pericarditis.
- Pleural EffusionMurakami isExperienced. Learn about Pleural Effusion.
- Trophoblastic Tumor Placental SiteMurakami isExperienced. Learn about Trophoblastic Tumor Placental Site.
- Type 2 Diabetes (T2D)Murakami isExperienced. Learn about Type 2 Diabetes (T2D).